Celevity logo — Empowering canine longevity with innovative medical solution...

Celevity

Empowering canine longevity with innovative medical solutions.

Founded 2019 51-200 employees Seed Total: $4.86M Biotechnology, Health Care +1

General Information

Company Name Celevity
Founded Year 2019
Employees 51-200
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Social

Get notified when Celevity moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Celevity

Celevity is a seed-stage company with the slogan "Empowering canine longevity with innovative medical solutions." The company, founded in 2019, is focused on developing drugs to extend the lifespan and improve the health of dogs. It views aging as a treatable condition and is working to create medicines to slow down and manage the aging process. Celevity's last investment was a $4.86M Seed Round led by BoxGroup, Longevity Fund, and Polymath Capital on 03 January 2020. Originating from Laura Deming’s The Longevity Fund, Celevity is based in San Francisco, California. The company operates within the Biotechnology and Health Care industries.

Taxonomy: Canine longevity, Medical solutions, Drug development, Lifespan extension, Aging management, Disease treatment, Veterinary medicine, Biotech startup, Seed-stage company, The Longevity Fund, San Francisco, Animal health, Pharmaceuticals, Biomedical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor Investor
•••• ••••
03 Jan 2020

Celevity Alternatives & Competitors

Celevity vs
Deep Longevity
Deep Longevity Hong Kong S.a.r.

Using Science of Longevity to Improve Healthspan & Lifespan

Series A
7 employees
Biotechnology, Health Care
Celevity vs

Discovering medicines to treat age-related diseases and extend the years of healthy living

Seed
4 employees
Health and Wellness, Manufacturing
Celevity vs
Hello100
Hello100 Lithuania

Hello100 is a biotech startup building a longevity platform to slow down aging.

Series Unknown
4 employees
Biotechnology, Health Care

FAQ About Celevity

Empowering canine longevity with innovative medical solutions.
Celevity was founded in 2019.
Celevity operates in the following industries: Biotechnology, Health Care, Life Sciences.
Celevity has approximately 51-200 employees.
Celevity has completed 1 funding round, raising a total of $4.86M. The latest funding stage is Seed.
Top alternatives and competitors to Celevity include Deep Longevity, Refoxy Pharma, Hello100 , Argeron, AutoPhagyGO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celevity and Deep Longevity are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Celevity and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes